Press Releases
GT Biopharma Hires Former Pfizer CMO/Vice President and Senior Director of Oncology Research as Chief Medical Officer
GT Biopharma, Inc, Announces Closing of OXIS International - Georgetown Translational Pharmaceuticals Merger
GT Biopharma, Inc. Announces Reverse Stock Spilt As Part of Oxis-Georgetown Planned Merger
GT Biopharma, Inc. (Oxis) Announces Corporate Update Conference Call With Incoming CEO Dr. Kathleen Clarence-Smith and Chairman Anthony Cataldo
GT Biopharma (OXIS) Announces Enrollment of Fourth Patient in FDA Phase 2 Trial of Cancer Drug OXS-1550
Oxis Releases Additional Details about Acquisition of Georgetown Translational Pharmaceuticals, Oxis to Change Name to "GT Biopharma, Inc."
USPTO Approves and Issues Patent for Oxis-4235 to Treat Multiple Myeloma
Oxis Agrees to Acquire Georgetown Translational Pharmaceuticals, Appoints New Chief Executive Officer and Chief Medical Officer
Oxis Enters into a Co-Development Partnership Agreement with Altor Bioscience for Novel TriKE Therapeutic
